{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:37:21Z","timestamp":1793047041316,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.schres.2026.06.003","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:40:16Z","timestamp":1781210416000},"page":"170-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serum Clozapine Levels and Dose\u2013Exposure Relationships in Indian Patients: A Cross-Sectional Study"],"prefix":"10.1016","volume":"295","author":[{"given":"G.R. Abigail","family":"Jane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niji Rachel","family":"Varughese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratna","family":"Prabha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Chichra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.06.003_bb0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0378-4347(98)00202-3","article-title":"Determination of clozapine, desmethylclozapine and clozapine N-oxide in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection","volume":"714","author":"Avenoso","year":"1998","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.schres.2026.06.003_bb0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/FTD.0000000000001184","article-title":"Validation of population pharmacokinetic models for clozapine dosage prediction","volume":"46","author":"Berneri","year":"2024","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.schres.2026.06.003_bb0015","article-title":"De novo seizures, obsessive compulsive symptoms and neutropenias in patients on clozapine: a retrospective cohort study","author":"Chichra","year":"2022","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.schres.2026.06.003_bb0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.30773\/pi.2022.0293","article-title":"Reflections on the lack of consideration of ethnic ancestry to stratify clozapine dosing","volume":"20","author":"de Leon","year":"2023","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.schres.2026.06.003_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/IJPSYM.IJPSYM_379_19","article-title":"Do Asian patients require only half of the clozapine dose prescribed for Caucasians? A critical overview","volume":"42","author":"de Leon","year":"2020","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.schres.2026.06.003_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/a-1625-6388","article-title":"An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels","volume":"55","author":"de Leon","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2026.06.003_bb0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/JCP.0000000000001987","article-title":"Letter to the FDA proposing major changes in the US clozapine package insert supported by clozapine experts worldwide. Part I: a review of the pharmacokinetic literature and proposed changes","volume":"45","author":"de Leon","year":"2025","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.06.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2025.104424","article-title":"Exploring the factors and outcomes of clozapine discontinuation in India: a retrospective analysis","volume":"106","author":"Elachola","year":"2025","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2026.06.003_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.forsciint.2013.03.021","article-title":"Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum","volume":"229","author":"Fisher","year":"2013","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.schres.2026.06.003_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/jspf.jspf_4_24","article-title":"Clozapine Use in Schizophrenia: Are We Underutilizing?","volume":"1","author":"Grover","year":"2023","journal-title":"J. SAARC Psychiatr. Fed."},{"key":"10.1016\/j.schres.2026.06.003_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104143","article-title":"An experience of using clozapine in elderly patients with mental disorders","volume":"98","author":"Grover","year":"2024","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2026.06.003_bb0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/acps.12673","article-title":"The significance of sampling time in therapeutic drug monitoring of clozapine","volume":"135","author":"Jakobsen","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.06.003_bb0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/JCP.0000000000001980","article-title":"The impact of therapeutic drug monitoring on clozapine dosing and clinical outcome in a tertiary Care Center in India: a retrospective study","volume":"45","author":"Jogi","year":"2025","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.06.003_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.120119","article-title":"Need to consider exact trough time: Comment on \u201cDaily dosing frequency as a determinant of clozapine concentration-to-dose ratio: Data from a therapeutic drug monitoring service (2019\u20132022).\u201d","volume":"567","author":"Kikuchi","year":"2025","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.schres.2026.06.003_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2025.104673","article-title":"Clozapine dose for Asians: an account from India","volume":"112","author":"Kumar","year":"2025","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2026.06.003_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1735337","article-title":"Exploratory analysis of non-linear clozapine dose-concentration relationship in real-life hospital database","volume":"16","author":"Mach","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.schres.2026.06.003_bb0085","first-page":"411","article-title":"Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia","volume":"52","author":"McElroy","year":"1991","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2026.06.003_bb0090","article-title":"Genetic and clinical factors affecting plasma clozapine concentration","volume":"17","author":"Olsson","year":"2015","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.schres.2026.06.003_bb0095","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/acps.12526","article-title":"PANSS-6: a brief rating scale for the measurement of severity in schizophrenia","volume":"133","author":"\u00d8stergaard","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.06.003_bb0100","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1176\/appi.ajp.20230744","article-title":"High burden of ileus and pneumonia in clozapine-treated individuals with schizophrenia: a Finnish 25-year follow-up register study","volume":"181","author":"Partanen","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.06.003_bb0105","first-page":"4","article-title":"Clinical predictors of response to clozapine in patients with treatment resistant schizophrenia","volume":"44","author":"Rajkumar","year":"2011","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.schres.2026.06.003_bb0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/bcp.15691","article-title":"A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking status","volume":"90","author":"Reeves","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2026.06.003_bb0115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.jcp.0000106221.36344.4d","article-title":"Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients","volume":"24","author":"Rostami-Hodjegan","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.06.003_bb0120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/JCP.0000000000001341","article-title":"European whites may need lower minimum therapeutic clozapine doses than those customarily proposed","volume":"41","author":"Schoretsanitis","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.06.003_bb0125","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cpt.1329","article-title":"\u201cAsian\u201d phenotype underestimates the genetic diversity of Asia yet overstates its impact on variability in drug disposition and pharmacodynamics","volume":"105","author":"Singh","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.schres.2026.06.003_bb0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.schres.2020.05.057","article-title":"Do Indian patients with schizophrenia need half the recommended clozapine dose to achieve therapeutic serum level? An exploratory study","volume":"222","author":"Suhas","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.06.003_bb0135","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/1462220031000158591","article-title":"Determination of tar, nicotine, and carbon monoxide yields in the smoke of bidi cigarettes","volume":"5","author":"Watson","year":"2003","journal-title":"Nicotine Tob. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426001787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426001787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:05:36Z","timestamp":1793045136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426001787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"alternative-id":["S0920996426001787"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.06.003","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Clozapine Levels and Dose\u2013Exposure Relationships in Indian Patients: A Cross-Sectional Study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}